Bio

Featured Partnership

Bio

Mammoth Biosciences

Mammoth Biosciences

Co-founded by Nobel Laureate Prof. Jennifer Doudna, Mammoth Biosciences is harnessing the diversity of nature to power the next generation of CRISPR products for addressing challenges across healthcare, agriculture, environmental monitoring, biodefense.

Bio

Beam Therapeutics

Beam Therapeutics

Beam Therapeutics is pioneering the use of base editing — a potential new class of precision genetic medicines — with a vision of providing life-long cures to patients suffering from serious diseases

Bio

PathAI

PathAI

PathAI is improving patient outcomes with reliable AI-Powered technology and meaningful collaboration with biopharma, laboratories, and clinicians — aiming to provide patients with access to accurate diagnoses and effective treatments

Bio

Ceribell

Ceribell

Ceribell has developed the world's first brain monitor for point-of-care seizure triage and treatment optimization

Bio

Alchemab Therapeutics

Alchemab Therapeutics

Alchemab Therapeutics is harnessing the power of the immune system to cure disease by using nature’s most effective search engine: Adaptive Immunity

Bio

CG Oncology

CG Oncology

CG Oncology is developing the next evolution of oncolytic immunotherapy for patients with advanced cancers

Bio

Totus Medicines

Totus Medicines

Totus Medicines is developing breakthrough chemical biology platform to make the entire human genome druggable, initially focusing on revolutionary drug program targeting PI3Kα, the most commonly mutated cancer oncogene

Bio

Engine Biosciences

Engine Biosciences

Engine Biosciences integrates machine learning and high-throughput experimental systems in a closed-loop to interrogate complex networks of gene interactions and pinpoint specific components for therapeutics and patient selection

Bio

Carbon Biosciences

Carbon Biosciences

Developer of gene therapy intended to treat cancer. The company is currently operating in Stealth mode.

Bio

Darmiyan

Darmiyan

Darmiyan is developing a commercial diagnostic software platform for the early detection, monitoring and stratification of Alzheimer’s disease (AD) and other neurodegenerative disorders through an innovative magnetic resonance (MR) image analysis technology

Bio

iSono Health

iSono Health

iSono Health has developed an AI-driven UltraSound platform for accessible and personalized health monitoring, ATUSA (FDA approved), that combines wearable ultrasound with an ML engine to transform breast cancer screening for millions of women every year

Bio

Namocell

Namocell

Namocell has developed single cell dispenser instruments that use proprietary microfluidics technology which flow cytometry and liquid dispensing to sort and dispense single cells for applications in cell line development and engineering, single cell genomics, iPSC and CRISPR cloning, antibody discovery, and rare cell isolation

Bio

Surge Therapeutics

Surge Therapeutics

Surge Therapeutics is developing platform to enable extended delivery of immunotherapy for cancer patient undergoing tumor resection

Bio

Strand Therapeutics

Strand Therapeutics

Strand Therapeutics is an emerging biopharmaceutical company applying synthetic biology to RNA therapeutics and developing the first platform for the creation of programmable, long-acting mRNA drugs capable of delivering precise, multi-functional, potentially curative treatments with a single dose

Bio

Vevo Therapeutics

Vevo Therapeutics

Vevo Therapeutics is developing high-throughput in-vivo drug discovery platform based on proprietary technology developed at UCSF

Bio

Viz.ai

Viz.ai

Viz.ai platform alerts multidisciplinary care teams earlier in the workflow, to coordinate care and connect frontline health care professionals to specialists and facilitate efficient communication and care coordination